NCT06934499Recruiting
Tunisian Lung Cancer Study
Clinical Observational Study on Tunisian Lung Cancer
Source: ClinicalTrials.gov · Last updated 4 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1334 (estimated)
- First submitted
- 11 Apr 2025
- Start date
- May 2025
- Primary completion date
- Oct 2025
- Lead sponsor
- Dacima Consulting
- Diseases
- Lung cancer
- NCT number
- NCT06934499
What you commit to
- Study type: Observational
- Planned participants: 1334
- From May 2025 to the primary completion date, Oct 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Age more than 18 years
- Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
- Informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tunisian Society of Medical Oncology Coordinator of this site? Confirm its status | Aryanah | Tunisia | Not yet recruiting |
| Tunisian Society of Respiratory Diseases and Allergology Coordinator of this site? Confirm its status | Tunis | Tunisia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.